氨酸通过聚胺合成调节CD8+ T细胞的抗瘤功能
Tian Zhao1,2, Gillian A Carleton1,2, Sarah Macpherson2,3
1Department of Biochemistry and Microbiology, University of Victoria, Victoria, BC, Canada.
bioRxiv : the preprint server for biology
|November 19, 2025
概括
氨酸限制 (MR) 可以通过抑制聚胺合成来提升T细胞的功能. 然而,在活体中,持续的MR会损害采用T细胞治疗的疗效,这表明增加氨酸的可用性可能是有益的.
科学领域:
- 免疫学 免疫学 免疫学
- 代谢途径 代谢途径
- 癌症治疗治疗 癌症治疗
背景情况:
- 氨酸对于T细胞激活至关重要.
- 氨酸限制 (MR) 和免疫检查点阻塞可以增强T细胞功能.
- 氨酸在采用T细胞治疗中的作用尚不清楚.
研究的目的:
- 调查 metionin 可用性对 T 细胞功能在采用性 T 细胞治疗中的影响.
- 探索 metionin 通过哪些机制影响 T 细胞活动 in vitro 和 in vivo.
主要方法:
- 使用了初级T细胞和小鼠采用T细胞治疗模型.
- 细胞接受过渡性或持续性氨酸限制 (MR) 或氨酸腺转移酶2A抑制剂 (MAT2Ai) 的治疗.
- 抗瘤疗效使用卵蛋白 (OVA) 特定的 (OT-I) CD8+ T细胞对EG7-OVA瘤进行了评估.
主要成果:
- 在体外,短暂的MR或MAT2Ai通过抑制聚胺合成,增加了CD8+T细胞中的IFNγ表达.
- 持续的MR上调了T细胞耗尽标记in vitro.
- 在体内,短暂的MR并没有提高抗瘤功效,而持续的MR则加速了瘤的生长.
结论:
- 过渡性MR通过抑制聚胺合成来增强T细胞的功能in vitro.
- 氨酸的可用性对于被收养转移的T细胞在体内疗效至关重要.
- 提高瘤微环境中的氨酸可用性可能会改善收养T细胞治疗的结果.
相关概念视频
Abnormal Proliferation
5.1K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.1K
Biosynthesis of Nucleic Acids
932
Nucleic acid biosynthesis is a fundamental biochemical process that produces the purine and pyrimidine nucleotides essential for DNA and RNA synthesis. This pathway maintains a balanced nucleotide pool, preventing imbalances that could jeopardize genetic integrity and cellular function. Given the crucial role of nucleotides, their synthesis is tightly regulated to ensure proper cellular homeostasis.Purine BiosynthesisThe biosynthesis of purine nucleotides begins with ribose-5-phosphate, a...
932
mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K
The Tumor Microenvironment
7.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.6K
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Mitogens and the Cell Cycle
7.7K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.7K


